Assignee: New York University

Location: New York, NY
No. of patents: 325

«First «Previous1 2 3 4 5 6 7 8 9 Next»Last»

Number	Title	Issue Date
8183225	Inhibition of bone resorption using medical implants containing adenosine receptor antagonists The invention provides methods and compositions for reducing or inhibiting bone resorption, osteoclast differentiation and stimulation and the loosening of medical prostheses by administering a compound or agent that modulates an adenosine receptor such as the adeno...	05/22/2012
8183040	Methods for in vitro differentiation of Th-17+cells The present invention is directed to an in vitro method for promoting differentiation and proliferation of human T helper lymphocytes that express IL17 (Th-IL17+ cells). The instant method may be used to generate a population of human T helper lymphocytes tha...	05/22/2012
8179577	Three-dimensional holographic ring traps A method and system for preparing and using three dimensional optical ring traps. The method and system includes applying a single phase hologram to be able to independently control shape and force profile of an optical trap but without employing orbital angular mom...	05/15/2012
8174742	System for applying optical forces from phase gradients A system and method for creating extended optical traps for applying optical forces to a material to be manipulated for a commercial application. The system and method include applying a hologram of appropriate characteristics to a beam of light wherein the hologram...	05/08/2012
8163748	s-Triazine compounds, pharmaceutical compositions and method of using the same Novel s-triazine compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of condi...	04/24/2012
8158380	Imaging agents for protein misfolding Charged and neutral small fluorescent molecules based upon the styryl scaffold are useful as imaging agents for misfolded proteins such as amyloid plaque. Charged molecules are prepared using pyrrolidine catalyzed reactions by solution-phase synthesis. Neutral styry...	04/17/2012
8157868	Implants for the treatment of osteoarthritis of the knee A replacement knee implant has a femoral implant and a tibial implant, each of which are inset in a bone surface. The tibial implant is generally elongated with one end rounded and an opposite end conforming to the shape of the tibia, and is made of a metal alloy or...	04/17/2012
8153863	Transgenic plants expressing and having increased nitrogen assimilation capacity Provided herein are compositions and methods for producing transgenic plants. In specific embodiments, transgenic plants comprise a construct comprising a polynucleotide encoding CCA1, GLK1 or bZIP1, operably linked to a plant-specific promote, wherein the CCA1, GLK...	04/10/2012
8142779	Treatment of follicular lymphomas using inhibitors of the LT pathway Therapeutic uses of inhibitors of the lymphotoxin pathway to treat tumors, specifically to treat follicular lymphomas. ...	03/27/2012
8140269	Methods, computer-accessible medium, and systems for generating a genome wide haplotype sequence Methods, computer-accessible medium, and systems for generating a genome wide probe map and/or a genome wide haplotype sequence are provided. In particular, a genome wide probe map can be generated by obtaining a plurality of detectable oligonucleotide probes hybrid...	03/20/2012
8133471	CLK-peptide and SLK-peptide The invention describes methods for inhibiting angiogenesis in a tissue by administering an antagonist that specifically binds to a proteolyzed or denatured collagen type-IV with substantially greater affinity than to the native triple helical form of collagen type-...	03/13/2012
8129341	Methods for treating diabetic wounds The present invention relates to a method of treating chronic wounds using calreticulin. In particular, the invention relates to the treatment of chronic diabetic wounds using topical application of calreticulin to a patient in need of such treatment. ...	03/06/2012
8128907	CSF biomarker dilution factor corrections by MRI imaging and algorithm A method is disclosed for providing a correcting factor for the dilution of measurements of at least one biomarker in cerebrospinal fluid (CSF). The method comprises providing semi-automated measurements of the ventricular system by MRI scans using quantitative anat...	03/06/2012
8124581	Methods for treating breast cancer using NRIF3 related molecules Disclosed herein is the discovery that administration of the NRIF3 family of transcriptional coregulators (NRIF3 and related molecules) to breast cancer cells induce rapid and profound apoptosis (nearly 100% cell death within 24 h). A novel death domain (DD1) was ma...	02/28/2012
8119421	Methods to identify compounds useful for the treatment of proliferative and differentiative disorders The present invention relates to the discovery, identification and characterization of nucleotide sequences that encode novel substrate-targeting subunits of ubiquitin ligases. The invention encompasses nucleotides encoding novel substrate-targeting subunits of ubiq...	02/21/2012
8112417	Method and system for data classification in the presence of a temporal non-stationarity A method and system for determining a feature of a particular pattern are provided. In particular, data records are received, and predetermined patterns that are associated with at least some of the data records are obtained. Using the system and method, particular ...	02/07/2012
8110181	Method of treating with interferons A method of treating tuberculosis comprising administering an aerosolized interferon such as interferon α, interferon β or interferon γ in a therapeutically effective amount is provided herein. Also, pharmaceutical compositions of one or more aerosolized i...	02/07/2012
8105572	Method of treating tuberculosis with interferons A method of treating tuberculosis comprising administering an aerosolized interferon such as interferon α, interferon β or interferon γ in a therapeutically effective amount is provided herein. Further, a method of reducing the infectivity of tuberculosis or redu...	01/31/2012
8105571	Method of treating pulmonary disease with interferons A method of treating a pulmonary disease such as, for instance idiophathic pulmonary fibrosis (IPF), mixed connective tissue disease and asthma, comprising administering an aerosolized interferon such as interferon γ in a therapeutically effective amount is provide...	01/31/2012
8103611	Architectures, systems, apparatus, methods, and computer-readable medium for providing recommendations to users and applications using multidimensional data Exemplary non-transitory computer-readable medium, method and system for providing at least one recommendation to users and applications using multidimensional data. The multidimensional data can define a multidimensional space defined by a Cartesian product of the ...	01/24/2012
8094318	Method and apparatus for determining reflectance data of a subject An apparatus for obtaining reflectance data of an object includes a diffuser having a surface. The apparatus includes a mapping portion that affects a mapping between a light field at the object's surface and a light field at the diffuser surface for BRDF capture of...	01/10/2012
8093365	Biocompatible materials containing stable complexes method of TSG-6 and hyaluronan and method of using same The present invention provides a biocompatible material in the form of a solid, a water insoluble cross-linked gel or a liposome, which contains a stable complexes of TNF-stimulated gene protein (TSG-6) and hyaluronan. ...	01/10/2012
8093043	β-TrCP1, β-TrCP2 and RSK1 or RSK2 inhibitors and methods for sensitizing target cells to apoptosis The invention relates to modulating BimEL levels (Bcl-2-Interacting Mediator of cell death, Extra Long isoform) to sensitize cancer cells to cell death or apoptosis. In certain embodiments, the invention relates to increasing BimEL levels. In certain embodiments, th...	01/10/2012
8093021	Defective sindbis viral vectors Disclosed herein are new defective Sindbis viral vectors made from a novel Helper plasmid, with differences in envelope proteins between JT vectors and consensus Sindbis virus sequences, and also between JT and Ar-339 vectors. Also disclosed are vectors produced usi...	01/10/2012
8090747	Method, system, computer-accessible medium and software arrangement for organization and analysis of multiple sets of data Exemplary embodiments of system, computer-accessible medium and method can be provided for organizing or analyzing at least two sets of data. The sets of data can be organized and/or analyzed by generating a data structure for the sets of data and comparing the data...	01/03/2012
8076309	USP47 inhibtors and methods to induce apoptosis The present invention relates to USP47 (ubiquitin specific protease 47) inhibitors and methods for inducing apoptosis or cell death in a target cell. In certain embodiments, the invention relates to methods and kits to screen for related agents that induce apoptosis...	12/13/2011
8067558	Constitutively active fragments of eukaryotic heat shock RNA The present invention provides a novel RNA, designated herein as the “HSR1” (Heat Shock RNA), constitutively active HSR1 fragments, and the use of HSR1 and constitutively active HSR1 fragments for generation of novel therapeutics for the treatment of various dis...	11/29/2011
8067230	Prostatic stem cells, isolation and uses Prostatic stem cells have been isolated. Benign prostatic hyperplasia and other proliferative diseases of the prostate may arise in prostatic stem cells. The prostatic stem cells are used as a research tool for studying cancer and other proliferative diseases of the...	11/29/2011
8067000	Cancer treatment with endothelin receptor antagonists The present invention relates to therapeutic protocols and pharmaceutical compositions designed to treat and prevent cancer. More specifically, the present invention relates to a novel method of treating cancer using antagonists to the endothelin B receptor (ETB) or...	11/29/2011
8064581	Method of associating multiple prepaid cards with a single account A set of multiple prepaid calling cards that are associated with a single account is disclosed. A predetermined amount of minutes is associated with the set of cards. Cards within the set can be used simultaneously and extract minutes from the account in predetermin...	11/22/2011
8062996	Plant glutamate receptors The present invention relates to a family of GluR in plants, including ionotropic (iGluR), metabotropic (mGluR) and other glutamate-like plant receptors. The plant GluRs of the invention may function as signal transducers involved in the regulation of plant growth. ...	11/22/2011
8060180	Multi-echo magnetic resonance imaging method and system Exemplary method, systems and arrangements can be provided for creating a high-resolution magnetic resonance image (“MRI”) or obtaining other information of a target. For example, radio-frequency (“RF”) pulses can be transmitted toward the target by a RF tra...	11/15/2011
8059321	Volumetric imaging of holographic optical traps A method and system for manipulating object using a three dimensional optical trap configuration. By use of selected hologram on optical strap can be configured as a preselected three dimensional configuration for a variety of complex uses. The system can include va...	11/15/2011
8050872	System and method for rapid searching of highly similar protein-coding sequences using bipartite graph matching An exemplary embodiment of system, computer-accessible medium and method for comparing a first genome to a second genome. For example, a first genome may be compared to a second genome by building a first library for the first genome and a second library for the sec...	11/01/2011
8044188	Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof The present invention relates to an isolated Clostridial neurotoxin propeptide having a light chain region, a heavy chain region, where the light and heavy chain regions are linked by a disulfide bond, and an intermediate region connecting the light and heavy chain ...	10/25/2011
8044101	Nitrosation-inducible inhibitors biological macromolecules Biomacromolecules such as proteins are inactivated by hydrophobic ANSA derivatives of the formula: wherein R1 and R2 are hydrophobic or affinity groups and R3 is selected from the group cons...	10/25/2011
8026110	Combinatorial rosamine library and uses thereof The present invention relates to a rosamine derivative compound, as described herein, having the following structure: Also disclosed are methods of making such compounds and for using them for detection and imaging. ...	09/27/2011
8020555	System and method for improved treatment of sleeping disorders using therapeutic positive airway pressure Described is a method and system providing therapeutic positive airway pressure to a particular area of patient's airways. The system may include a flow generator and a processing arrangement. The flow generator supplies an airflow to an airway of the patient. The p...	09/20/2011
8015127	System, method, and computer-accessible medium for providing a multi-objective evolutionary optimization of agent-based models Agent-based models (ABMs)/multi-agent systems (MASs) are one of the most widely used modeling-simulation-analysis approaches for understanding the dynamical behavior of complex systems. These models can be often characterized by several parameters with nonlinear int...	09/06/2011
8012936	Tau fragments for immunotherapy The present invention relates to methods of treating and preventing Alzheimer's Disease or other tauopathies in a subject by administering a tau protein, its immunogenic epitopes, or antibodies recognizing the tau protein or its immunogenic epitopes under conditions...	09/06/2011

«First «Previous1 2 3 4 5 6 7 8 9 Next»Last»

PatentStorm

Bizarre Patents

PatentStorm News

Assignee: New York University